XNCRXencor Inc
+7.9% today · +177.6% over a year
1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 28% of the instruments we score
Trend: among the best of its peers; priced higher than most peers. No dividend.
Xencor Inc (XNCR) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €2.6B. Over the past 12 months the price changed by +177.6%, with an annualised volatility of 65% and a largest fall of 43%.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 338)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Accrualsweighs on the score · better than 7% of peers
- 12-month trend (ex last month)supports the score · better than 80% of peers
- Revenue growth (5 y, a year)weighs on the score · better than 13% of peers
Red flags and notes
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Caution. Share count growing 3–10 % a year over three years. More in the glossary → Share count growing 3–10 % a year over three years.
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 5.2
- P/S
- 14.4
- Free-cash-flow yield
- −6.1%
- Market cap (EUR)
- €2.6B
Profitability and debt
- Return on equity
- −19.9%
- Return on invested capital
- −22.0%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +7.9%
- 1 month
- +56.7%
- 1 year
- +177.6%
- Volatility, 1 yr
- 64.6%
- Max drawdown, 1 yr
- −42.6%
- Beta
- 0.97
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| XERSXeris Biopharma Holdings Inc. | 6/10 | 0.0% | 113.5% |
|---|---|---|---|
| AVAHAveanna Healthcare Holdings Inc. | 5/10 | 0.0% | 50.9% |
| ACADACADIA Pharmaceuticals Inc | 3/10 | 0.0% | −26.9% |
| ATRCAtriCure | 9/10 | 0.0% | 80.3% |
| ADMAADMA Biologics Inc | 2/10 | 0.0% | −11.9% |
| VCELVericel Corp | —/10 | 0.0% | 49.9% |
| IRTCiRhythm Holdings | 2/10 | 0.0% | −49.2% |
| BEAMBeam Therapeutics | 1/10 | 0.0% | 21.7% |
News and filings
- Xencor Inc: 10-Q — Quarterly report for the period ending 30 Sep 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 4 Nov 2026
- Xencor Inc: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 4 Nov 2026
- Xencor Inc: 8-K — Results of operations; Regulation FD disclosure; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 26 Oct 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 2 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 1/10 | 1 · — | removed: Financial distress | Available with Invest Pro | |
| First rating | 1/10 | 1 · — | Serious warning. Altman Z in the distress zone and negative free cash flow. More in the glossary → | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.